Matthew Schellenberg

10PUBLICATIONS
57CO-AUTHORS
Molecular targetsHaematological tumoursProteins and peptidesBiomaterialsQuality assurance, chemometrics, traceability and metrological chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 23, 2026
Pharmacological correlates of topoisomerase II-directed protection against anthracycline-induced DNA damage and cardiotoxicity: a comparative evaluation of catalytic topoisomerase II inhibitors.

|Jul 23, 2026
Analysis of gene expression changes upon topobexin treatment and TOP2B-knockout in hiPSC-derived cardiomyocytes.

|May 21, 2026
Molecular basis of allosteric regulation and pharmaceutical targeting of protein kinase Cβ.

|May 27, 2025
Topobexin targets the Topoisomerase II ATPase domain for beta isoform-selective inhibition and anthracycline cardioprotection.

Jan Kubeš, Galina Karabanovich, Anh T Q Cong

|Mar 07, 2024
Dimerization-dependent serine protease activity of FAM111A prevents replication fork stalling at topoisomerase 1 cleavage complexes.

Sowmiya Palani, Yuka Machida, Julia R Alvey

|Dec 19, 2023
Endoxifen downregulates AKT phosphorylation through protein kinase C beta 1 inhibition in ERα+ breast cancer.

Swaathi Jayaraman, Xinyan Wu, Krishna R Kalari

Pageof 2

Frequent Collaborators

5 joint publications

Anh T Q Cong

3 joint publications

Caroline Austin

3 joint publications

Jan Kubeš

3 joint publications

Julia R Alvey